Photoprotective behaviours in inflammatory bowel disease patients on azathioprine and TNF-α inhibitors

被引：0
|
作者：
Gallagher, C. [1 ,2 ]
Ridge, A. [3 ]
Tobin, A. M. [1 ,4 ]
Kevans, D. [5 ]
McNamara, D. [1 ,6 ]
机构：
[1] Adelaide & Meath Hosp, Dublin, Ireland
[2] Natl Childrens Hosp, Dept Clin Med, Dublin, Ireland
[3] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[4] Natl Childrens Hosp, Dept Dermatol, Dublin, Ireland
[5] St James Hosp, Coll Dublin, Dept Gastroenterol, Dublin, Ireland
[6] Natl Childrens Hosp, Dept Clin Med & Gastroenterol, Dublin, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P184
引用
收藏
页码：S169 / S170
页数：2
相关论文
共 50 条
  • [31] A Role of iRhom2 for the Secretion of TNF-α in Inflammatory Bowel Disease
    Hwang, Sung Wook
    Chun, Jaeyoung
    Lee, Changhyun
    Im, Jong Pil
    Kim, Joo Sung
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S829 - S829
  • [32] Infliximab:: mechanism of action beyond TNF-α neutralization in inflammatory bowel disease
    Kirman, I
    Whelan, RL
    Nielsen, OH
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (07) : 639 - 641
  • [33] Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists
    McConachie, Sean M.
    Wilhelm, Sheila M.
    Bhargava, Ashish
    Kale-Pradhan, Pramodini B.
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (06) : 571 - 579
  • [34] OPTIMAL DURATION OF MAINTENANCE TREATMENT WITH AZATHIOPRINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Pica, R.
    Avallone, E. V.
    Cassieri, C.
    Pieroni, A.
    Di Camillo, M.
    De Carolis, A.
    Marinelli, I.
    Vernia, P.
    Paoluzi, P.
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S181 - S181
  • [35] Azathioprine induced neutropenia as a predictor of relapse in inflammatory bowel disease patients
    Campbell, S
    Ghosh, S
    [J]. GUT, 2000, 46 : A14 - A14
  • [36] The Role of TPMT in Gastrointestinal Intolerance to Azathioprine in Inflammatory Bowel Disease Patients
    Bastida, Guillermo
    Nos, Pilar
    Aguas, Mariam
    Beltran, Belen
    Iborra, Marisa
    Nevarez, Andrea
    Moret, Ines
    Rausell, Francisco
    Ponce, Julio
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A175 - A175
  • [37] Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
    Vernier-Massouille, G.
    Cosnes, J.
    Lemann, M.
    Marteau, P.
    Reinisch, W.
    Laharie, D.
    Cadiot, G.
    Bouhnik, Y.
    De Vos, M.
    Boureille, A.
    Duclos, B.
    Seksik, P.
    Mary, J-Y
    Colombel, J-F
    [J]. GUT, 2007, 56 (10) : 1404 - 1409
  • [38] Optimal duration of maintenance treatment with azathioprine in patients with inflammatory bowel disease
    Pica, Roberta
    Avallone, Eleonoraveronica
    Cassieri, Claudio
    De Carolis, Aurora
    Zippi, Maddalena
    Vernia, Piero
    Paoluzi, Paolo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 805 - 805
  • [39] FEVER DUE TO AZATHIOPRINE IN TREATMENT OF PATIENTS WITH AN INFLAMMATORY BOWEL-DISEASE
    COCCO, AE
    PAVLIDES, GP
    [J]. MARYLAND STATE MEDICAL JOURNAL, 1977, 26 (06) : 61 - 62
  • [40] AWARENESS OF ADVERSE EFFECTS OF AZATHIOPRINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Spence, A. D.
    Lee, R.
    Keegan, D.
    Doherty, G. A.
    Mulcahy, H.
    O'Donoghue, D.
    Murphy, S. J.
    [J]. GUT, 2013, 62
12345